Healthcare
Sociedade Portuguesa de Diabetologia and the Ordem dos Médicos Demand Infarmed Revoke the 13 April Glucose-Sensor Circular — Generic Prescription Treats Two Medical Devices With Different Age Approvals and Different Apps as Interchangeable
SPD president Estevão Pape and Ordem dos Médicos bastonário Carlos Cortes call Infarmed's 13 April circular a 'clinical setback'. The shift from brand-specific to generic prescription treats two CGM sensors as interchangeable — but one is approved age 2+, the other age 18+, and the apps don't talk.
